Vortioxetine

Back to search

Molecule Structure

Scientific Name

Vortioxetine

Description of the Drug

Vortioxetine is a serotonin modulating antidepressant indicated for the treatment of major depressive disorder (MDD).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB09068

Brand Name(s)

Brintellix

Company Owner(s)

Takeda Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Serotonin 3a (5-HT3a) receptor SINGLE PROTEIN ANTAGONIST CHEMBL1899
Serotonin 1a (5-HT1a) receptor SINGLE PROTEIN AGONIST CHEMBL214
Serotonin transporter SINGLE PROTEIN INHIBITOR CHEMBL228

Unichem Links

SureChEMBL SCHEMBL236115
PharmGKB PA166122595
DrugBank DB09068
PubChem: Thomson Pharma 14942974
PubChem 9966051
LINCS LSM-45585
Nikkaji J3.095.728H
BindingDB 50400902
DrugCentral 4806
ChemicalBook CB62614395
Guide to Pharmacology 7351
GSRS 8037c5dc-2eea-4de4-b955-4c3c38c6deff
rxnorm TRINTELLIX VORTIOXETINE VORTIOXETINE HYDROBROMIDE
ChEBI 76016
ZINC ZINC000034051848